Phase I Randomized Study of CPX for the Treatment of Adult Patients With Mild Cystic Fibrosis
Status:
Completed
Trial end date:
1999-10-01
Target enrollment:
Participant gender:
Summary
OBJECTIVES: I. Evaluate the safety of ascending doses of CPX administered to adult patients
with mild cystic fibrosis.
II. Evaluate the pharmacokinetics of ascending doses of CPX in this patient population.